NASDAQ:GLMD - Galmed Pharmaceuticals Stock Price, Forecast & News

Galmed Pharmaceuticals trades on the NASDAQ under the ticker symbol "GLMD."

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) posted its quarterly earnings data on Wednesday, November, 6th. The biopharmaceutical company reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.11. View Galmed Pharmaceuticals' Earnings History.

Galmed Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Galmed Pharmaceuticals.

5 brokerages have issued 12 month price targets for Galmed Pharmaceuticals' shares. Their forecasts range from $10.00 to $59.00. On average, they expect Galmed Pharmaceuticals' stock price to reach $30.50 in the next year. This suggests a possible upside of 400.8% from the stock's current price. View Analyst Price Targets for Galmed Pharmaceuticals.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Galmed Pharmaceuticals in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Galmed Pharmaceuticals.

News headlines about GLMD stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Galmed Pharmaceuticals earned a news sentiment score of 1.5 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Galmed Pharmaceuticals.

Galmed Pharmaceuticals saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 465,500 shares, an increase of 6.1% from the November 28th total of 438,700 shares. Based on an average daily trading volume, of 114,900 shares, the short-interest ratio is presently 4.1 days. Approximately 3.2% of the company's stock are short sold. View Galmed Pharmaceuticals' Current Options Chain.

Some companies that are related to Galmed Pharmaceuticals include Molecular Templates (MTEM), Mallinckrodt (MNK), Clovis Oncology (CLVS), OrganiGram (OGI), Milestone Pharmaceuticals (MIST), Dynavax Technologies (DVAX), CytoDyn (CYDY), Organogenesis (ORGO), Ardelyx (ARDX), Corbus Pharmaceuticals (CRBP), Sinovac Biotech (SVA), Arcus Biosciences (RCUS), Assembly Biosciences (ASMB), Rigel Pharmaceuticals (RIGL) and Fulcrum Therapeutics (FULC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Galmed Pharmaceuticals investors own include Opko Health (OPK), Viking Therapeutics (VKTX), Rite Aid (RAD), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Immunomedics (IMMU), Portola Pharmaceuticals (PTLA), Verastem (VSTM), Micron Technology (MU) and NVIDIA (NVDA).

Shares of GLMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GLMD stock can currently be purchased for approximately $6.09.

Galmed Pharmaceuticals has a market capitalization of $128.00 million and generates $2.04 million in revenue each year. The biopharmaceutical company earns $-9,860,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis. Galmed Pharmaceuticals employs 17 workers across the globe.View Additional Information About Galmed Pharmaceuticals.

The official website for Galmed Pharmaceuticals is http://www.galmedpharma.com/.

Galmed Pharmaceuticals' mailing address is 16 TIOMKIN STREET, TEL AVIV L3, 6578317. The biopharmaceutical company can be reached via phone at 972-3693-8448.